Menu
  • Join
  • Login
  • Contact
 

Search abstracts


A STUDY ON SELECTED APPROVED NEW CHEMICAL ENTITIES BY USFDA AND FORECASTING THE UNIT SALES IN THE PROPOSED GENERIC R&D PORTFOLIO

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: AJAY, Maram (Manipal College of Pharmaceutical Sciences, Manipal University, Hyderabad, India)
  • Co-author(s): N Udupa
  • Abstract:

    Generic drugs are considered as an economical alternative to innovator drugs yet keeping in mind the quality, safety and efficacy intact. Generic drugs have gained a major interest due to various reasons like economic factors due to which major Indian companies entered generic market places through various regulatory approvals like USFDA in the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses